{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:49:55Z","timestamp":1753886995764,"version":"3.41.2"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2018,3,6]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Diminished growth hormone (\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              ) is associated with impaired endothelial function and fibrinolysis.\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              \u2010releasing hormone is the primary stimulus for\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              secretion and a substrate of dipeptidyl peptidase\u20104. We tested the hypothesis that dipeptidyl peptidase\u20104 inhibition with sitagliptin increases stimulated\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              secretion, vasodilation, and tissue plasminogen activator (\n              <jats:styled-content style=\"fixed-case\">tPA<\/jats:styled-content>\n              ) activity.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Healthy adults participated in a 2\u2010part double\u2010blind, randomized, placebo\u2010controlled, crossover study. First, 39 patients (29 women) received sitagliptin or placebo on each of 2\u00a0days separated by a washout. One hour after study drug, blood was sampled and then arginine (30\u00a0g IV) was given to stimulate\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              . Vasodilation was assessed by plethysmography and blood sampled for 150\u00a0minutes. Following a washout, 19 of the original 29 women received sitagliptin alone versus sitagliptin plus antagonist to delineate\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              receptor (\n              <jats:styled-content style=\"fixed-case\">GHR<\/jats:styled-content>\n              )\u2013 (n=5), nitric oxide\u2013 (n=7), or glucagon\u2010like peptide\u20101 receptor\u2013 (n=7) dependent effects. Sitagliptin enhanced stimulated\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              secretion (\n              <jats:italic>P<\/jats:italic>\n              &lt;0.01 versus placebo, for 30\u00a0minutes) and free insulin\u2013like growth factor\u20101 (\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001 versus placebo, after adjustment for baseline) in women. Vasodilation and\n              <jats:styled-content style=\"fixed-case\">tPA<\/jats:styled-content>\n              increased in all patients, but sitagliptin enhanced vasodilation (\n              <jats:italic>P<\/jats:italic>\n              =0.01 versus placebo) and increased\n              <jats:styled-content style=\"fixed-case\">tPA<\/jats:styled-content>\n              (\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001) in women only.\n              <jats:styled-content style=\"fixed-case\">GHR<\/jats:styled-content>\n              blockade decreased free insulin\u2013like growth factor\u20101 (\n              <jats:italic>P<\/jats:italic>\n              =0.04 versus sitagliptin alone) and increased stimulated\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              (\n              <jats:italic>P<\/jats:italic>\n              &lt;0.01), but decreased vascular resistance (\n              <jats:italic>P<\/jats:italic>\n              =0.01) such that nadir vascular resistance correlated inversely with\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              (\n              <jats:italic>r<\/jats:italic>\n              <jats:sub>s<\/jats:sub>\n              =\u22120.90,\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001).\n              <jats:styled-content style=\"fixed-case\">GHR<\/jats:styled-content>\n              blockade suppressed\n              <jats:styled-content style=\"fixed-case\">tPA<\/jats:styled-content>\n              . Neither nitric oxide nor glucagon\u2010like peptide\u20101 receptor blockade affected vasodilation or\n              <jats:styled-content style=\"fixed-case\">tPA<\/jats:styled-content>\n              .\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Sitagliptin enhances stimulated\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              , vasodilation, and fibrinolysis in women. During sitagliptin, increases in free insulin\u2013like growth factor\u20101 and\n              <jats:styled-content style=\"fixed-case\">tPA<\/jats:styled-content>\n              occur via the\n              <jats:styled-content style=\"fixed-case\">GHR<\/jats:styled-content>\n              , whereas vasodilation correlates with\n              <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\n              but occurs through a\n              <jats:styled-content style=\"fixed-case\">GHR<\/jats:styled-content>\n              \u2010independent mechanism.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Clinical Trial Registration<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">URL<\/jats:styled-content>\n              :\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">http:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n              . Unique identifier:\n              <jats:styled-content style=\"fixed-case\">NCT<\/jats:styled-content>\n              01701973.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.117.008000","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T02:16:18Z","timestamp":1519611378000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Dipeptidyl Peptidase\u20104 Inhibition Potentiates Stimulated Growth Hormone Secretion and Vasodilation in Women"],"prefix":"10.1161","volume":"7","author":[{"given":"Jessica R.","family":"Wilson","sequence":"first","affiliation":[{"name":"Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy J.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Nian","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[{"name":"Endocrine Laboratory, Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica K.","family":"Devin","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1990.tb11600.x"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1470523"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2021"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030144"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0609"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2013.08.005"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2007.11.001"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0092-8"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02691.x"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/434562"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000027563.44593.CC"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-8-200310210-00007"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3968"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0169"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112679"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(65)90399-5"},{"key":"e_1_3_5_18_2","first-page":"1072","article-title":"Insights from growth hormone receptor blockade","volume":"5","author":"Muller AF","year":"2004","unstructured":"Muller AF, van der Lely AJ. Insights from growth hormone receptor blockade. Curr Opin Investig Drugs. 2004;5:1072\u20131079.","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0662-7"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.2310\/6650.2002.31273"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0605"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/hy0202.103054"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1201\/9781420036091"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196906262802603"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1349"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.1.86"},{"key":"e_1_3_5_27_2","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina A","year":"1998","unstructured":"Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998;19:717\u2013797.","journal-title":"Endocr Rev"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.01.015"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12453"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2908"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030246"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.280.3.E489"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-200002000-00012"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346667"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.05726"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2007.01.009"},{"key":"e_1_3_5_37_2","first-page":"43","article-title":"L\u2010arginine stimulates NO\u2010dependent vasodilation in healthy humans\u2014effect of somatostatin pretreatment","volume":"47","author":"Bode\u2010Boger SM","year":"1999","unstructured":"Bode\u2010Boger SM, Boger RH, Loffler M, Tsikas D, Brabant G, Frolich JC. L\u2010arginine stimulates NO\u2010dependent vasodilation in healthy humans\u2014effect of somatostatin pretreatment. J Investig Med. 1999;47:43\u201350.","journal-title":"J Investig Med"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119095"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02109.x"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0763"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001075"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.739938"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.11.7987"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(69)90095-X"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1258\/ebm.2009.009186"},{"key":"e_1_3_5_46_2","first-page":"249","article-title":"Reproducibility and variability of the arginine test in normal adults. Comparison between sexes","volume":"59","author":"Fideleff HL","year":"1999","unstructured":"Fideleff HL, Frigeri AE, Sobrado PG, Llano MN, Ruibal GF, Boquete HR. Reproducibility and variability of the arginine test in normal adults. Comparison between sexes. Medicina (B Aires). 1999;59:249\u2013253.","journal-title":"Medicina (B Aires)"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.117.008000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:01:51Z","timestamp":1715598111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.117.008000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3,6]]}},"alternative-id":["10.1161\/JAHA.117.008000"],"URL":"https:\/\/doi.org\/10.1161\/jaha.117.008000","relation":{},"ISSN":["2047-9980"],"issn-type":[{"type":"electronic","value":"2047-9980"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"2017-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e008000"}}